China
· Delayed Price · Currency is CNY Shanghai Fosun Pharmaceutical (Group) Statistics
Total Valuation
Shanghai Fosun Pharmaceutical (Group) has a market cap or net worth of CNY 53.71 billion. The enterprise value is 84.16 billion.
| Market Cap | 53.71B |
| Enterprise Value | 84.16B |
Important Dates
The next estimated earnings date is Monday, October 28, 2024.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | Aug 6, 2024 |
Share Statistics
Shanghai Fosun Pharmaceutical (Group) has 2.67 billion shares outstanding. The number of shares has increased by 0.40% in one year.
| Shares Outstanding | 2.67B |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | +1.61% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 14.80% |
| Float | 1.70B |
Valuation Ratios
The trailing PE ratio is 33.10 and the forward PE ratio is 23.33.
| PE Ratio | 33.10 |
| Forward PE | 23.33 |
| PS Ratio | 1.49 |
| PB Ratio | 1.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.29, with an EV/FCF ratio of -86.20.
| EV / Earnings | 45.87 |
| EV / Sales | 2.08 |
| EV / EBITDA | 22.29 |
| EV / EBIT | 59.38 |
| EV / FCF | -86.20 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 58.88.
| Current Ratio | 0.93 |
| Quick Ratio | 0.69 |
| Debt / Equity | 58.88 |
| Debt / EBITDA | 9.18 |
| Debt / FCF | -35.50 |
| Interest Coverage | 0.99 |
Financial Efficiency
Return on equity (ROE) is 4.20% and return on invested capital (ROIC) is 0.97%.
| Return on Equity (ROE) | 4.20% |
| Return on Assets (ROA) | 0.78% |
| Return on Capital (ROIC) | 0.97% |
| Revenue Per Employee | 1.03M |
| Profits Per Employee | 46,672 |
| Employee Count | 40,370 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 2.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.61% in the last 52 weeks. The beta is 0.65, so Shanghai Fosun Pharmaceutical (Group)'s price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -19.61% |
| 50-Day Moving Average | 22.87 |
| 200-Day Moving Average | 23.88 |
| Relative Strength Index (RSI) | 44.21 |
| Average Volume (20 Days) | 7,951,448 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shanghai Fosun Pharmaceutical (Group) had revenue of CNY 40.47 billion and earned 1.83 billion in profits. Earnings per share was 0.68.
| Revenue | 40.47B |
| Gross Profit | 18.99B |
| Operating Income | 1.42B |
| Pretax Income | 2.54B |
| Net Income | 1.83B |
| EBITDA | 3.45B |
| EBIT | 1.42B |
| Earnings Per Share (EPS) | 0.68 |
Balance Sheet
The company has 16.10 billion in cash and 34.66 billion in debt, giving a net cash position of -18.56 billion or -6.96 per share.
| Cash & Cash Equivalents | 16.10B |
| Total Debt | 34.66B |
| Net Cash | -18.56B |
| Net Cash Per Share | -6.96 |
| Equity (Book Value) | 58.86B |
| Book Value Per Share | 17.58 |
| Working Capital | -2.60B |
Cash Flow
In the last 12 months, operating cash flow was 3.51 billion and capital expenditures -4.49 billion, giving a free cash flow of -976.29 million.
| Operating Cash Flow | 3.51B |
| Capital Expenditures | -4.49B |
| Free Cash Flow | -976.29M |
| FCF Per Share | -0.37 |
Margins
Gross margin is 46.92%, with operating and profit margins of 3.50% and 4.53%.
| Gross Margin | 46.92% |
| Operating Margin | 3.50% |
| Pretax Margin | 6.28% |
| Profit Margin | 4.53% |
| EBITDA Margin | 8.52% |
| EBIT Margin | 3.50% |
| FCF Margin | -2.41% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 1.20%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 1.20% |
| Dividend Growth (YoY) | -35.71% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 136.05% |
| Buyback Yield | -0.40% |
| Shareholder Yield | 0.80% |
| Earnings Yield | 3.02% |
| FCF Yield | -1.63% |
Stock Splits
The last stock split was on July 26, 2010. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 26, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5 |